前收市價 | 37.07 |
開市 | 37.54 |
買盤 | 37.53 x 800 |
賣出價 | 39.00 x 800 |
今日波幅 | 37.49 - 39.14 |
52 週波幅 | 34.09 - 109.52 |
成交量 | |
平均成交量 | 385,052 |
市值 | 408.912M |
Beta 值 (5 年,每月) | 1.17 |
市盈率 (最近 12 個月) | 4.12 |
每股盈利 (最近 12 個月) | 9.10 |
業績公佈日 | 2024年4月29日 - 2024年5月03日 |
遠期股息及收益率 | 6.60 (17.59%) |
除息日 | 2023年9月18日 |
1 年預測目標價 | 37.50 |
MEDIFAST (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medifast (MED) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
With the growing demand for telemedicine, the market could be worth about $450 billion by the time 2032 rolls around. That’s according to Emergen Research. By 2034, it could hit $888.1 billion, says Prophecy Market Insights. All creating big opportunities for telemedicine stocks. First made popular during the pandemic, it’s become a much-needed fixture for a lot of patients who just don’t want to drive to the doctor or sit in the waiting room. Unless there’s a medical emergency that requires a d